In an effort to understand how brain cells exchange chemical messages, scientists say they have successfully used a highly ...

Scientists at Pennington Biomedical Research Center have gained greater clarity in the brain regions and neurons that control metabolism, body temperature and energy use.

Scientists at Pennington Biomedical Research Center have gained greater clarity in the brain regions and neurons that control ...

Opioid use disorder is associated with more than 350,000 deaths annually worldwide. Guided by the need for an increased ...

Scientists at Pennington Biomedical Research Center have gained greater clarity in the brain regions and neurons that control metabolism, body temperature and energy use. Featured in the February ...

Tempero Bio has raised $70m in Series B financing to advance its lead candidate TMP-301 through two clinical trials for ...

The Series B round will help the Aditum Bio-backed startup fund two mid-stage clinical trials in people with alcohol and cocaine use disorders.

The company, launched with help from ex-Novartis executives, is targeting glutamate signaling in the brain to help treat ...

PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative ...

Tempero Bio, Inc., a clinical-stage biopharmaceutical company developing transformative treatments for substance use disorders, today announced the closing of a $70 million Series B financing. The ...